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Abstract
In the clinical setting, the early detection of myocardial injury induced by doxorubicin (DXR) is still considered a
challenge. To assess whether ultrasonic tissue characterization (UTC) can identify early DXR-related myocardial
lesions and their correlation with collagen myocardial percentages, we studied 60 rats at basal status and
prospectively after 2mg/Kg/week DXR endovenous infusion. Echocardiographic examinations were conducted at
baseline and at 8,10,12,14 and 16 mg/Kg DXR cumulative dose. The left ventricle ejection fraction (LVEF), shortening
fraction (SF), and the UTC indices: corrected coefficient of integrated backscatter (IBS) (tissue IBS intensity/ phantom
IBS intensity) (CC-IBS) and the cyclic variation magnitude of this intensity curve (MCV) were measured. The variation
of each parameter of study through DXR dose was expressed by the average and standard error at specific DXR
dosages and those at baseline. The collagen percent (%) was calculated in six control group animals and 24 DXR
group animals. CC-IBS increased (1.29±0.27 x 1.1±0.26-basal; p=0.005) and MCV decreased (9.1± 2.8 x 11.02±2.6-
basal; p=0.006) from 8 mg/Kg to 16mg/Kg DXR. LVEF presented only a slight but significant decrease (80.4±6.9% x
85.3±6.9%-basal, p=0.005) from 8 mg/Kg to 16 mg/Kg DXR. CC-IBS was 72.2% sensitive and 83.3% specific to detect
collagen deposition of 4.24%(AUC=0.76). LVEF was not accurate to detect initial collagen deposition (AUC=0.54). In
conclusion: UTC was able to early identify the DXR myocardial lesion when compared to LVEF, showing good
accuracy to detect the initial collagen deposition in this experimental animal model.
Keywords: Doxorubicin, Ultra-sonic tissue characterization, Echocardiography, Rats
Introduction
Cardiotoxicity is one of the most feared complications
related to doxorubicin (DXR) prescription in clinical
practice, expressed primarily by myocardial focal scler-
osis, which can evolve to irreversible ventricular diastolic
and systolic dysfunctions.
Serial quantification of left ventricle ejection fraction
(LVEF) is the standard procedure to identify cardiotoxi-
city [1], but it is not sensitive enough to detect initial
myocardial lesion [2,3]. Information regarding myocar-
dial ultra-structure and composition, including the
collagen deposition, can be provided by ultrasonic tissue
characterization (UTC), a non-invasive technique that
can detect and quantify acoustic properties of myocar-
dial tissue [4,5]. Even though UTC has been used to de-
tect myocardial damage in several myocardial collagen
deposition diseases [6-10], its ability to do so in DXR
cardiotoxicity is still debated. There is evidence of UTC
abnormalities at the end of the DXR infusion [11-13]. In
a previous pilot study performed in our laboratory
(results yet not published), with rats receiving intraperi-
toneal DXR infusions, we found that UTC can poten-
tially detect the myocardium texture alterations at the
end of treatment with DXR, even in occasions where
there was only a slight decrease in LVEF.
This study was designed to assess the capability of
UTC to detect myocardium injury due to DXR infusion
earlier than LVEF, as evaluated using echocardiography
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in an experimental animal model and with histological
quantification of collagen deposition.
Methods
Study population
Sixty adults Wistar male rats (250 to 300g) were sedated
and evaluated with echocardiographic examinations at basal
situation as previously described [14]. Then, the animals
received weekly endovenous DXR infusions of 2mg/Kg
DXR up to a cumulative dosage of 16 mg/Kg. The animals
were sedated and submitted to echocardiographic evalua-
tions 7–15 days after the cumulative dosages of 8, 10, 12,
14, and 16 mg/Kg DXR. The protocol was approved by the
Ethical Animal Research Committee of our institution,
according to the Brazilian College Rules in Animal Experi-
mentation (Protocol 041/2005).
Two-dimensional conventional echocardiography
Two-dimensional echocardiography was performed,
using an ultra-sound Sonos 5500, Philips (Andover, MA)
equipment with S12-MHz sectorial probe. The paraster-
nal short axis view at the papillary level was used to ob-
tain chamber dimensions according to the M Mode
technique — diastolic interventricular septal (IVS) and
posterior wall (PW) thickness, end diastolic (LVEDD) and
end systolic left ventricular diameters (LVESD). M-Mode
images were obtained in a sweep speed of 100–150 mm/s
what seems to have an adequate frame rate to an animal
with a heart rate of 300bpm. These parameters were used
to calculate the ejection fraction (EF) by Teichholz
method [15] and shortening fraction (SF). Heart rate was
measured with pulsed Doppler and all measurements
were expressed as the average of three consecutive cardiac
cycles.
Ultrasonic tissue characterization
Two-dimensional ultrasonic backscatter images were
obtained using an online acoustic densitometry package,
incorporated in the same image system, from a paraster-
nal short axis view at the papillary muscle level. Images
were captured in a cineloop, displayed and stored for
off-line analysis as follows: Backscatter (IBS) was
measured from an elliptical sample placed over the pos-
terior myocardium wall and made as large as possible,
avoiding the epicardium and endocardium. The IBS
values obtained were calibrated for system settings and
for attenuation, by dividing the average value by the IBS
value obtained from a rubber phantom (ATS Laborator-
ies, 15 × 15 × 15cm, 15 db) for each segment, at the
same depth. The IBS values of the phantom were
obtained from backscattered echoes emanating from
within the phantom at the same depth of the tissue that
was analyzed (Figure 1). This variable was nominated as
the corrected coefficient of the IBS (CC IBS). A second
variable extracted from the IBS measurements was the
magnitude of cardiac cyclic variation (MCV) of the IBS,
Figure 1 Technical aspects of CC-IBS acquisition. Upper left: parasternal view and sample collection of AII (Intensity signal) values of
myocardium; lower left: AII curve of signals emanating from tissue; Upper right: sample collection of AII values from a rubber phantom at same
depth, maintaining the same equipment adjustments; Lower right: AII curve signals emanating from the rubber phantom.
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as measured by the peak-to-peak intensity (PPI) differ-
ence between maximal and minimal values of IBS in the
cardiac cycle.
Histological analysis
Six control group animals, eight DXR group animals
with cumulative dosage of 8 mg/Kg, six DXR group ani-
mals with cumulative dosage of 12 mg/Kg and ten DXR
group animals with cumulative dosage of 16 mg/Kg were
sacrified after sedation and submitted to histological
analyses.; whole hearts were excised, fixed, and cross-
sectionally cut at the papillary muscle level. Samples
were colored with hematoxilin-eosin and red picrosirius,
this last one for the collagen quantification. For each
heart, ten randomly selected areas through the whole left
ventricular wall, excepting the septum, were analyzed.
Collagen was quantified with the Leica Qwin Software V
3.2.0 (Leica Imaging Systems Ltd., Cambridge, England)
incorporated into an optical Leica DMR microscope
(Leica Mycrosystems Wetzlar GmbH, Wetzlar, England),
a video camera (Leica DC300F, Leica Mycrosysrems AG,
Heerbrugg, Switzerland) and a computer station. Colla-
gen amount was expressed as percentage of the mea-
sured area.
Statistical analysis
Categorical variables were compared among all the
groups with Fishers’ or Chi-Square tests and continuous
variables with Kruskal-Wallis tests. To eliminate the ef-
fect of repeated measurements in the same animal, lin-
ear regression coefficient (beta coefficient) was obtained
for each animal, utilizing the dependent variable and
each DXR cumulative doses. Spearman test was used to
evaluate the relation between beta coefficients and colla-
gen percentage values. The receiver-operating (ROC)
curve was elaborated according to a 4.24% collagen con-
tent (higher than the average value of the control group,
plus 2 standard deviations) to determine the accuracy of
both CC-IBS and left ventricular ejection fraction. All
analyses were performed with STATA Intercool versão
9.2 (Stata Satistical Software 9,2 [computer program].
College Station TX StataComp; 2005).
Results
Sixty animals were analyzed at baseline. Table 1 presents
the DXR group data at basal and at DXR cumulative
dosages of 8, 10, 12, 14 and 16 mg/Kg expressed as aver-
age and standard error values.
The microscopic study of the myocardium revealed that
the control hearts did not present any pathological
change. The microscopic findings in the myocardium in
all doxorubicin-treated groups were described as intracel-
lular edema, vacuolar degeneration, and disorganization
or loss of myofibrils. Loss of myofibrils and vacuolar
degeneration of cardiomyocytes were predominantly char-
acterized by alterations in the doxorubicin cardiomyop-
athy, more pronounced in the myocardium of the
doxorubicin groups treated with 12 and 16 mg/kg
(Figure 2).
Collagen content increased through DXR infusion from
8 mg/Kg (5.6±1.6% x 1.7±0.6-basal; p=0.001) (Figure 3,
panel D). With each DXR incremental dose, there was a
continuous increase of CC-IBS and decrease in LVEF
(Figure 3-panels A and C). CC-IBS increased significantly
with a DXR cumulative dosage of 8 mg/Kg (1.29±0.27 x
1.1±0.26-basal; p=0.005), with a subsequent increase at 12
mg/Kg dosage (1.4±0.2 x 1.1±0.26-basal p=0.005); while
MCV decreased from 8 mg/Kg DXR dosage (9.1± 2.8 x
11.02±2.6-basal; p=0,006) (Figure 3-panel B) and remained
stable after. The decrease in LVEF at DXR cumulative dos-
age of 8 mg/Kg was lower than 6% (80.4±6.9% x 85.3
±6.9%-basal, p=0.005). At the same cumulative dose (8 mg/
Kg DXR), CC-IBS increased nearly 20% from basal values,
reaching a 30-40% increment at 12mg/Kg DXR (Figure 3-
panels A and C). Figure 4 illustrates actual ultrasonic find-
ings, with IBS calculations from animals in different DXR
dosages. There was a significant correlation between colla-
gen content and beta coefficient of CC-IBS (r=0.45,
p=0.02) (Figure 5 – panel A) but no correlation was
observed between collagen content and MCV (r= 0.06,
p=0.76) (Figure 5-panel B), LVEF- Teichholz (r= −0.20,
p=0.33) (Figure 5- panel C), and SF (r=−0.09, p=0.65)
(Figure 5- panel D).
LV ejection fraction was not accurate enough to de-
tect initial myocardium collagen deposition (4.24% of
myocardial content) (AUC=0.54) (Figure 6-panel A).
CC-IBS was able to detect the collagen deposition
induced by DXR, with good accuracy (AUC=0.76). A
CC-IBS value of 1.21 was able to detect initial colla-
gen deposition (4.24% of myocardial content) with a
Table 1 DXR group data at basal and at DXR cumulative
dosages of 8, 10, 12, 14 and 16 mg/Kg expressed in
average and standard error values
DOXORUBICIN
DOSE 0 8 10 12 14 16
N 60 23 21 14 9 7
MCV 11.0 ±2.6 9.1 ±2.8 8.4 ±2.3 8.2± 2 7.2 ±1.5 8.8 ±0.6
CC IBS 1.1 ±0.3 1.3± 0.27 1.2 ±0.1 1.4± 0.2 1.3 ±0.2 1.4 ±0.1
LVEF
(%)
85.3± 6.9 80.4± 6.9 81.3± 5.6 76.4± 6.6 75.6± 4.8 67.3± 10
SF (%) 50±7.3 45.2 ±6.9 45.3 ±5.4 40.8 ±6.4 39.9 ±4.2 33.4± 7
Col (%) 1.7 ± 0.6 5.6± 1.6 10.6 ±2.5 9.6± 0.7
(N=6)* (N=8) * (N=6)* (N=10)*
N=animal number; MCV= magnitude of cyclic variation of IBS; CC
IBS= corrected coefficient of IBS; EF Teic= Left ventricle ejection fraction
(Teichholz); SF=left ventricle shortening fraction; Col=collagen percentage.*
number of animals submitted to collagen analysis.
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Figure 3 Average values of CC-IBS (panel A), magnitude of IBS cyclic variation- MCV (panel B) and LVEF by Teichholz method (panel C)
throughout cumulative DXR dosages in basal and DXR treated animals. Panel D shows collagen percent detected in each DXR cumulative
dosages groups. *=p<0.05 between dosages.
Figure 2 Hystopathologic analysis of myocardial samples stained with hematoxilin and eosin from control (panel A) and doxorubicin
groups (8 mg/Kg- panel B; 12 mg/Kg- panel C and 16 mg/Kg- panel D). Note that vacuolar degeneration, disorganization and loss of
myofibrils are more pronounced with the increment of DXR cumulative doses (panel B-D). Arrows mark points of vacuolar degeneration and
intracellular edema.
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Figure 4 Examples of IBS intensity values from rats of different cumulative DXR dosages.
Figure 5 Correlation analysis between collagen content (%) and beta coefficient of: CC-IBS (panel A); magnitude of IBS cyclic variation
-MCV (panel B); LVEF using Teichholz formula (panel C) and SF (panel D). r= Spearman correlation coefficient and e p significative <0,05.
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sensitivity of 72.2% and specificity of 83.3% (Figure 6-
panel B).
Discussion
To the best of our knowledge this is the first evidence
that UTC, by using CC-IBS, can detect the initial myo-
cardial lesion (collagen deposition) secondary to DXR in-
fusion early than clinical significant LVEF decrease. Our
results are congruent with previously published data
[16] showing that this experimental animal model of
DXR infusion reproduces pathologic myocardial altera-
tions similar to those found in human disease.
At the end of the DXR infusion protocol, LVEF de-
crease was about only 6% at 8 mg/Kg DXR and about
10% at 12 mg/Kg. This result is in agreement with previ-
ously published data showing that the LVEF decreases
slightly at 12 weeks of DXR infusion [17-20].
Information regarding myocardial ultra-structure and
composition can be provided by ultrasonic tissue
characterization, a non-invasive technique capable of
detecting and quantifying acoustic properties of myocar-
dial tissue (4;5). The IBS intensity is related to physical
and structural properties of the myocardium and is par-
ticularly influenced by tissue collagen content and spatial
distribution of this component [21]. In addition, IBS in-
tensity also depends on ultrasound system settings and
on ultrasound attenuation, which has been a major limi-
tation for the current use of this index. In order to over-
come this limitation, several methods have been
employed to calibrate the absolute value of IBS accord-
ing to a reference value, derived from the ventricular
cavity [22], the pericardium [7] or from a gray scale
phantom [23] [13] such as the one used in this investiga-
tion. Although absolute IBS values derived from ven-
tricular cavity or pericardium could reduce the influence
of the ultrasound system settings, there are limitations
for their use so as to correct the effects of ultrasound at-
tenuation; This, associated to the fact that the pericar-
dium membrane (and consequently its IBS intensity)
could be affected by DXR toxicity, influenced our choice
of a rubber phantom referential for this investigation.
There is little published data about CC-IBS in this ani-
mal model, but Mimbs, studying rabbits, has already
demonstrated CC-IBS increments at the end of the total
cumulative dose of DXR infusion. In this study we
reproduced their findings, but we were also able to dem-
onstrate a dose–response relationship beginning at an
8mg/Kg cumulative dose. Also, CC-IBS was the only
index with a significant correlation with collagen depos-
ition, secondary to DXR infusion. The capability of IBS
in detecting fibrosis content of the myocardium was
already described in several diseases, including dilated
cardiomyopathy [22,24].
During cardiac contraction and relaxation, a cardiac
cycle-dependent variation of myocardial IBS can be
documented. The magnitude of cyclic variation of the
IBS, measured as peak-to-peak variation of the IBS curve
(MCV), is an additional acoustic parameter, independent
on ultrasound system settings and responsible for its
wider application. However, this index is more strictly
correlated with the myocardial contractile function than
the collagen myocardial content. Previously published
data showed a decrease in MCV with DXR infusion
[11,20,25], even when LVEF was preserved. However,
Ha et al., using the same experimental animal model
described in our study, failed to demonstrate the decrease
in MCV with DXR infusion [17]. Considering that our in-
vestigation evaluated MCV through the whole infusion
DXR protocol, our results are the first to demonstrate that
MCV decrease occurs at initial cumulative DXR dosages
(8mg/Kg). MCV of IBS could be used, in addition to CC-
IBS, to detect early myocardial DXR toxicity. MCV of IBS
Figure 6 Lef ventricle ejection fraction accuracy analysis (Panel A) and CC-IBS (Panel B) to detect a 4.24% myocardial collagen content.
ROC= Receive-operating curve; AUC= area under the curve; IC= confident interval.
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may be more related to the myocardium contractile func-
tion than collagen content. If so, the reduction of MCV
from initial dosages of DXR infusion may accompany ini-
tial contraction impairment, as suggested in recent studies
[26-29] using regional contraction analysis techniques like
“strain rate”. Maybe cellular loss, which is the initial myo-
cardium damage before full collagen deposition, could be
detected with these tools (MCV of IBS and by myocar-
dium deformation analysis data, like strain, strain rate and
speckle tracking techniques) in a similar way.
The good accuracy of CC-IBS, as demonstrated here,
suggests that this parameter could be a non-invasive tool
to detect initial collagen deposition secondary to DXR
infusion, and it may have the potential to be used as an
alternative tool for serial evaluation of myocardial
lesions in the clinical setting.
Clinical applicability: this work confirms the capabil-
ity of UTC using CC-IBS to detect the initial myocardial
DXR lesion earlier than the decrease of LVEF in rats.
The UTC technique using the CC-IBS is feasible in ser-
ial myocardial assessments in humans. As such, this
study brings a perspective in the use of UTC as a non-
invasive method in collagen myocardium detection, and
as an alternative tool for endomyocardial biopsies, with
good accuracy, but human studies are needed.
Limitations: the anatomo-pathological studies were
limited to the rats that completed the protocol phase
and which had not suffered spontaneous deaths. In fact,
if those who died were included more striking differ-
ences could have been obtained, but adding some con-
founding factors. The high mortality rates at final
cumulative dosages of DXR limited the number of
animals analyzed at this point. This study did not in-
clude other pathologic myocardium analysis methods,
such as myocardial fibers diameter quantification, ultra-
structural myocardial analysis, or analysis of the tridi-
mensional myocardial arrangement that could be better
correlated to UTC indices like MCV. Another significant
limitation is the lack of diastolic data. Since our acoustic
window was limited and did not permit a collection of
distinct validated diastolic dysfunction parameters, we
preffer to exclude it from the protocol. A specific proto-
col can be developed from this work to address this
issue. In summary, UTC was able to identify the DXR
myocardial lesion earlier when compared to LVEF, show-
ing good accuracy to detect the initial collagen depos-
ition in this experimental animal model.
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